Our Doctors

Scott G. Foxman, M.D.
Founder and President
Retinal and Ophthalmic Consultants, P.C.

Retina Specialist


1500 Tilton Road, Northfield, NJ 08225

2466 East Chestnut Avenue, Vineland, NJ 08361

211 South Main Street, Cape May Court House, NJ 08210


1973 - 1979                 B.A. Boston University Medical Honors Program, Boston University

1975 - 1979                 M.D. Boston University Medical Honors Program, Boston University


1979                            National Eye Institute


1979 - 1980                 Intern in Medicine, Jackson Memorial Hospital, Miami

1980 - 1983                 Resident in Ophthalmology University of Minnesota, Minneapolis

1983 - 1985                 Fellowship, Vitreo-retinal Diseases Jules Stein Eye Institute, UCLA, Los Angeles


1983 - 1985                 Visiting Lecturer Jules Stein Eye Institute University of California

1986 - Present             Courtesy Scheie Eye Institute University of Pennsylvania School of Medicine

1986 - 1996                 Associate Attending Ophthalmologist Division of Ophthalmology Atlantic Regional Medical Center

1997 - Present             Chief, Division of Ophthalmology Atlantic Regional Medical Center

1986 - Present             Assistant Attending Ophthalmologist Division of Ophthalmology Shore Memorial Hospital


1979 -                          Diplomat of The National Board of Medical Examiners

1984 -                          Diplomat of The American Board of Ophthalmology

LICENSURE:             Pennsylvania, New Jersey, California


National Societies   

American Society of Retina Specialists
American Academy of Ophthalmology
American Medical Association
Association for Research in Vision and Ophthalmology
American Board of Ophthalmology

Local Societies  

Medical Society of New Jersey
Medical Society of Atlantic County
Academy of Medicine of New Jersey
New Jersey Academy of Ophthalmology
Retina Society of New Jersey


  • Atlantic Regional Medical Center
  • Shore Medical Center
  • Betty Bacharach Rehabilitation Hospital
  • Scheie Eye Institute      


  • University of Penn
  • Courtesy Staff


  • Past President
    Atlantic County Medical Society

  • Past President
    Lions Club Vision Care Center


  • Business Editor
    American Society of Retina Specialists


SAKURA-Principal Investigator
Santen Incorporated
June 2011-Present

Protocol No. 32-007: A Phase III, Multinational, Multi-Center, Randomized,
Double-Masked Study Assessing the Safety and Efficacy of Intravitreal Injections
of DE-109 (three doses) for the Treatment of Active, Non-Infectious Uveitis of
the Posterior Segment of the Eye.

SHORE-Principal Investigator
May 2011-Present

BB-IND 8633-Protocol FVF4967g: A Multi-Center Randomized Study
Evaluating Dosing Regimens for Treatment with Intravitreal Ranibizumab
Injections in Subjects with Macular Edema Following Retinal Vein Occlusion.
April 2011-Present

VIEW 1 EXTENTION – Sub-Investigator

Open-label, long-term, safety and tolerability extension study of intravitreal VEGF Trap-Eye in neovascular age-related macular degeneration.

NAION-Principle Investigator

Prospective case crossover study to assess whether PDE5 inhibitor exposure in men with erectile dysfunction increases the risk for the development of non-arteritic anterior ischemic optic neuropathy (NAION).


Randomized, Double-masked, controlled phase III study of the efficacy, safety and tolerability of repeated administration of VEGF Trap-Eye in subjects with macular edema secondary to central retinal vein occlusion (CRVO).

HARBOR-Principle Investigator

Phase III, double-masked, multi-center, randomized, active treatment, controlled study of the efficacy and safety of 0.5 mg and 2.0 mg Ranibizumab; administered monthly or on an as-needed-basis (PRN) in patients with subfoveal neovascular age-related macular degeneration.

DAVINCI- Sub-investigator

A double-masked, randomized, controlled study of the safety, tolerability and biological effect of repeated intravitreal administration of VEGF Trap-Eye in patients with diabetic macular edema (DME).

RISE - Principle Investigator
2008 – Present

3 year multi center study with monthly visits for patients with Diabetic Macular Edema comparing Lucentis with Standard of Care Laser treatments.

CRUISE - Principle Investigator
2008 – 2010

1 year multi center study with monthly visits comparing Lucentis to sham procedure for patients with central retinal vein occlusion.

VIEW1 - Sub-Investigator
2007 – Present

2 year multi center study with monthly visits comparing VEGF-Trap against Lucentis for patients with newly diagnosed age-related macular degeneration.

SIRIUS - Sub-Investigator
2006 – 2008

2 year multi center study comparing Sirna against Lucentis for age-related macular degeneration

NOTAL VISION HMP-V4 - Sub Investigator
Notal Vision

Sensitivity of the Home Macular Perimeter (HMP) in detection of choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD)

SAILOR - Principal Investigator
Genentech, Inc.
2003 – 2007

1 year multi center study to evaluate the safety and tolerability of Lucentis in newly diagnosed and previously treated subjects with age-related macular degeneration.             

Visudyne Photodynamic Therapy - Sub-Investigator
Ciba Vision

Clinical Investigator for Visudyne Photodynamic Therapy Study.

Flibanserin - Sub-Investigator
University of Pennsylvania and Boehringer Ingelheim (BI Trial No.

8 week, double-blind, placebo controlled Phase II study of various doses of     
flibanserin and paroxetine in patients with Major Depressive Disorder.  Our role was to
perform ophthalmic examinations to evaluate for potential ocular complications and side

Pioglitazone - Sub- Investigator
Takeda America, Inc.

A double-blind placebo-controlled, randomized, dose-titration study to evaluate the
safety and efficacy of pioglitazone, an oral hypoglycemic agent.  Our role was to perform
retinal examinations and evaluate retinal photographs for evidence of diabetic

Adefovir Dipivoxil (bis-POM PMEA) - Sub - Investigator

A placebo-controlled study of the safety and efficacy of adefovir dipovoxil (bis-POM
PMEA) in prolonged survival of HIV-infected individuals with a CD4+ cell count of <
100/mm3.  Our role was for ophthalmic evaluation with emphasis on the presence or
absence of CMV retinitis.

Silicone Oil - Principle Investigator
Richard James Corporation

Principal Investigator.  Clinical investigation as to the utility and safety of silicone oil
injection in the vitreous cavity for patients with complicated retinal detachment.  Our role
was to provide patient care including vitreoretinal surgery.

Perfluorocarbon Liquid - Principle Investigator
Retinal and Ophthalmic Consultants, P.C.

Clinical investigation as to the utility and safety of intra-operative use of perfluorocarbon
liquid into the vitreous cavity during surgical reattachment of the retina.  

Sulfur hexafluoride and Perfluoropropane - Sub - Investigator
Retinal and Ophthalmic Consultants, P.C.

Clinical investigation as to the utility and safety of long-acting gases in the repair of
retinal detachments.

Diabetic Retinopathy
National Institutes of Health
Early Treatment of Diabetic Retinopathy Study (ETDRS)

Dr. Scott Foxman was investigator in landmark national collaborative randomized trial of laser treatment for diabetic retinopathy.


Original Papers

  • Ballantine, E., Foxman, S., Gorden, P., Roth, J.:  Rarity of Diabetic Retinopathy in Patients with Acromegaly.  Arch. Intern. Med. 1981; 141:1625-1627.

  • Foxman, S., Cameron, J.D.:  The Clinical Implications of Bilateral Microphthalmos with Cyst:  Report of a Fatal Case.  Am. J. Ophthalmol.  1984;97:632-638.

  • Foxman, S., Heckenlively, J., Bateman, J., Wirtschafter, J.:  A Classifications of Congenital and Early Onset Retinitis Pigmentosa.  Arch. Ophthalmol.  1985;103:1502-1506.

  • Foxman, S., Heckenlively, J., Sinclair, S.:  Pigmented Paravenous Retinochoroidal Atrophy and Rubeola Retinopathy. Am. J. Ophthalmol.  1985;99:605-606.

  • Fishman, M., Kerman, B., Foxman, S.:  Intraocular Cysticercus:  Migratory.  Ossonig, K. (ed):  Proceedings of the 10th SIDUO Congress, Netherlands, W. Junk, 1986.

  • Heckenlively, J., Foxman, S., Parelhoff, E.:  Retinal Dystrophy and Macular Coloboma.  Doc Ophthal.  1988:68:257-271. Shields, J., Perez, N., Shields, C., Foxman, S., Foxman, B.: Simultaneous Choroidal and Brain Metastasis as Initial Manifestations of Lung Cancer.  Ophthalmic Surgery and Lasers.  2002:35:323-325.

  • Foxman, S.: Finding the right fit: Considerations on both sides of the employment process.  Retina Times.  2006: 24: 25-27.

  • Foxman, S.: Office Administrator: The guide of your practice’s success.  Retina Times. 2006: 24: 47-51. 

  • Ferencz L, Lang J, Yeshurn I, Pollack A, Siegel R, Lifshitz T, Karp J et al.  Toward earlier detection of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2010 March.

  • Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigators. Ranibizimab for macular edema following central retinal vein occlusion: six month primary end point results of phase III study.  Ophthalmology. 2010 June; 117(6):1124-1133.e1.

Click here for additional information regarding research studies and publications by Dr. Foxman.

back to top


Our nationally recognized doctors include:

Retina Service

Glaucoma Service

Cornea Service

Oculoplastic Service

Services Provided At:

Each facility includes state-of-the-art equipment including:
  • » Lasers
  • » Ultrasound
  • » Optical Coherence Tomography
  • » Ophthalmic Photography
  • » Fluorescein Angiography